Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 22471341)

Published in Am J Transplant on April 04, 2012

Authors

J M Miro1, M Montejo, L Castells, A Rafecas, S Moreno, F Agüero, M Abradelo, P Miralles, J Torre-Cisneros, J D Pedreira, E Cordero, G de la Rosa, B Moyano, A Moreno, I Perez, A Rimola, Spanish OLT in HIV-Infected Patients Working Group investigators

Author Affiliations

1: Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain. jmmiro@ub.edu

Associated clinical trials:

Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients (RAL-LT-HIV) | NCT02995824

Articles citing this

Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection. AIDS (2016) 1.45

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol (2016) 1.02

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States. Clin Infect Dis (2015) 0.90

Recurrence of hepatitis C after liver transplantation. Ann Gastroenterol (2013) 0.88

Screening guidelines for non-AIDS defining cancers in HIV-infected individuals. Curr Opin Oncol (2013) 0.87

Role of liver transplantation in human immunodeficiency virus positive patients. World J Gastroenterol (2015) 0.85

Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient. Infect Dis Clin North Am (2013) 0.84

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults. Can J Infect Dis Med Microbiol (2013) 0.84

Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience. HPB (Oxford) (2013) 0.83

Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (2016) 0.82

Hepatitis C virus-HIV-coinfected patients and liver transplantation. Curr Opin Organ Transplant (2015) 0.76

Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol (2014) 0.76

Pros and cons of liver transplantation in human immunodeficiency virus infected recipients. World J Gastroenterol (2014) 0.76

Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons. PLoS One (2015) 0.75

MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study). Medicine (Baltimore) (2015) 0.75

Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus. Clin Transplant (2016) 0.75

Liver transplantation: The effect of new HCV drugs on liver transplantation outcomes. Nat Rev Gastroenterol Hepatol (2015) 0.75

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. Can J Infect Dis Med Microbiol (2016) 0.75

Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study. Infection (2017) 0.75

A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients. AIDS Res Ther (2017) 0.75

Articles by these authors

Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol (1991) 33.90

The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26

Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89

Phosphorylation at Thr167 is required for Schizosaccharomyces pombe p34cdc2 function. EMBO J (1991) 4.59

Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ (2000) 3.65

Conservation of mitotic controls in fission and budding yeasts. Cell (1989) 3.65

Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature (1998) 3.36

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology (1993) 3.28

Alternative strategies for stroke care: a prospective randomised controlled trial. Lancet (2000) 3.27

Compensated cirrhosis: natural history and prognostic factors. Hepatology (1987) 3.01

Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells. Mol Cell Biol (1989) 2.75

Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73

A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. Am J Trop Med Hyg (2001) 2.73

Complementation of the mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase. Science (1990) 2.63

[Current status of tuberculosis in Spain. A precarious health care perspective with regard to developed countries]. Med Clin (Barc) (1995) 2.58

[CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection]. Med Clin (Barc) (1994) 2.56

Expression of the SV40 promoter in fission yeast: identification and characterization of an AP-1-like factor. Cell (1988) 2.44

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42

Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology (1990) 2.31

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology (1994) 2.27

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature (1988) 2.26

Catalytic wet peroxide oxidation of phenol by pillared clays containing Al-Ce-Fe. Water Res (2005) 2.25

Gastrointestinal bezoars. Br J Surg (1994) 2.21

Failure of mebendazole treatment in Giardia lamblia infection. Trans R Soc Trop Med Hyg (1990) 2.16

Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncol Rep (2012) 2.16

Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14

Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates. Am J Transplant (2015) 2.08

[Endocarditis caused by non-diphtheriae Corynebacterium. Presentation of 12 cases and review]. Enferm Infecc Microbiol Clin (1993) 2.07

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) (2001) 2.00

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology (1996) 2.00

Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol (1999) 1.92

Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis (1989) 1.90

Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol (2001) 1.89

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86

Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (1987) 1.85

Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology (1998) 1.83

Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82

Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78

Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology (1988) 1.76

NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem (1998) 1.75

Alendronate for treatment of renal transplant patients with osteoporosis. Transplant Proc (2003) 1.75

A dot hybridisation assay for detection of rotavirus. Lancet (1983) 1.75

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology (1988) 1.73

Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology (1984) 1.73

B-type cyclins regulate G1 progression in fission yeast in opposition to the p25rum1 cdk inhibitor. EMBO J (1996) 1.71

Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69

Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med (1993) 1.69

Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology (1993) 1.67

Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax (2001) 1.66

Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg (2000) 1.65

Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart (2005) 1.65

Risk assessment and anticoagulation for primary stroke prevention in atrial fibrillation. Stroke (1999) 1.63

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology (1990) 1.63

The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation (2001) 1.63

Flp1, a fission yeast orthologue of the s. cerevisiae CDC14 gene, is not required for cyclin degradation or rum1p stabilisation at the end of mitosis. J Cell Sci (2001) 1.63

Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect (2012) 1.61

Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology (1998) 1.60

Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun (2001) 1.60

Cacao domestication I: the origin of the cacao cultivated by the Mayas. Heredity (Edinb) (2002) 1.59

Genetic relatedness among human rotaviruses as determined by RNA hybridization. Infect Immun (1982) 1.58

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS (2001) 1.56

Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant (2011) 1.54

Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis (1992) 1.54

Differential effects of cytochalasin D and 2,3 butanedione monoxime on isometric twitch force and transmembrane action potential in isolated ventricular muscle: implications for optical measurements of cardiac repolarization. J Cardiovasc Electrophysiol (1998) 1.54

Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology (1996) 1.52

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer (2000) 1.52

Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum. J Exp Med (2000) 1.50

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology (1985) 1.50

Primary structure and inhibition of protein synthesis in eukaryotic cell-free system of a novel thionin, gamma-hordothionin, from barley endosperm. Eur J Biochem (1990) 1.49

Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg (2000) 1.49

The fission yeast Cdc1 protein, a homologue of the small subunit of DNA polymerase delta, binds to Pol3 and Cdc27. EMBO J (1996) 1.49

Cyclosporine-associated mutism in liver transplant patients. Neurology (1996) 1.49

'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ (2002) 1.49

Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients. J Infect (2012) 1.46

Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt. Am J Gastroenterol (1995) 1.46

Extra-anatomic venous graft for portal vein thrombosis in liver transplantation. Transpl Int (1997) 1.45

Lupus vulgaris. Clinical, histopathologic, and bacteriologic study of 10 cases. J Am Acad Dermatol (1992) 1.44

Regulation of the G1 phase of the cell cycle by periodic stabilization and degradation of the p25rum1 CDK inhibitor. EMBO J (1998) 1.43

Characterization of the genes coding for the putative sigma factor AlgU and its regulators MucA, MucB, MucC, and MucD in Azotobacter vinelandii and evaluation of their roles in alginate biosynthesis. J Bacteriol (1996) 1.42

[Comparative efficacy of oral deflazacort versus oral prednisolone in children with moderate acute asthma]. An Pediatr (Barc) (2004) 1.42

Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation. Transpl Infect Dis (2014) 1.41

Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause? Nephron (1989) 1.41

Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. Am J Clin Nutr (1980) 1.40

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology (1988) 1.40

[Cytokines value as a sepsis and mortality predictor in elderly patients with fever]. Med Clin (Barc) (2003) 1.40

Post-transplant lymphoproliferative disorders in children: the role of chemotherapy in the era of rituximab. Pediatr Transplant (2009) 1.40

[Usefulness of the somatostatin analog SMS 201-995 in the treatment of diarrhea in patients infected with the human immunodeficiency virus]. Med Clin (Barc) (1990) 1.40

Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review. Transplant Proc (2010) 1.39

[Immunoglobulin A as a prognostic factor in infection by human immunodeficiency virus type 1]. Med Clin (Barc) (1991) 1.39

[Factorial and discriminant analyses of neuropsychological variables in familial and sporadic late onset Alzheimer disease]. Rev Neurol (2005) 1.39

[Infective endocarditis caused by coagulase-negative staphylococci: a review of 19 cases]. Med Clin (Barc) (1989) 1.39

Stimulation by thimerosal of histamine-induced Ca(2+) release in intact HeLa cells seen with aequorin targeted to the endoplasmic reticulum. Cell Calcium (2001) 1.39

[Real incidence of fibrinolysis in acute myocardial infarct at a regional intensive care unit]. Rev Clin Esp (1990) 1.39

[Beware: hazards in the hospital dining room!]. Med Clin (Barc) (1990) 1.39

[Improvement in the results of surgical resection of hepatocellular carcinoma]. Gastroenterol Hepatol (2001) 1.39